Neurocrine Biosciences Inc. (NBIX) - Earnings & Price History

NBIX: Neurocrine Biosciences Inc. - 59.03, $5.21B, 0.07 (0.12%)

Sector: Healthcare - Industry: Drugs - Generic

Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The companys products in clinical development stage include elagolix, which is in Phase III study for endometriosis and uterine fibroids; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2) that is in Phase III study for tardive dyskinesia, as well as in Phase II study for tourette syndrome; and NBI-640756, which is in Phase I study for essential tremor. Its research programs comprise Corticotropin-Releasing Factor Receptor1 Antagonist for congenital adrenal hyperplasia; VMAT2 Inhibitors for movement disorders, bipolar disorders, and schizophrenia; and G Protein-Coupled Receptors and Ion Channels for epilepsy, essential tremor, pain, and other Indications. It has collaborations with AbbVie Inc. to develop and commercializ

Past NBIX reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-14AMC-0.5642.4541.5342.4441.62442.19%0.02%2.22%1.03M
2016-11-02AMC-0.5740.1642.5644.6739.9145.54.96%▲-10.10%-5.64%2.27M
2016-08-03AMC-0.4950.0850.3450.5649.8951.860.44%-0.95%-0.52%882.84K
2016-05-05AMC-0.2942.8742.6541.6940.8644.07-2.25%2.83%0.52%1.12M
2016-04-29AMC-0.29
2016-04-28AMC-0.2945.5846.946.7345.0947.47-0.36%-2.46%-2.81%696.62K
2016-02-11AMC-0.3236.0435.3735.9533.6536.481.64%0.25%1.89%1.84M
2016-02-08AMC-0.3232.1932.5131.8731.2533.86-1.97%1.00%-0.98%1.19M
2015-10-29AMC-0.2549.0949.9747.547.550.43-4.94%▲3.35%-1.76%1.21M
2015-04-30BMO-0.334.0937.1336.2533.1637.49-2.37%-5.96%-8.19%2.63M
2015-02-09AMC-0.2435.8333.5433.7633.7636.70.66%6.13%6.83%1.79M
2014-11-03AMCNeurocrine Bios-0.2117.6218.1518.1517.5818.22-2.92%-2.92%598.20K
2014-08-06AMCNeurocrine Bios-0.17-0.1813.3313.8213.9313.214.490.80%-4.31%-3.55%640.20K
2014-04-30AMCNeurocrine Bios-0.19-0.1713.3614.0214.0712.9514.270.36%-5.05%-4.71%1.12M
2014-02-06AMCNeurocrine Bios-0.17-0.1616.9516.1216.0315.4617.05-0.56%5.74%5.15%1.33M
2013-10-29AMCNeurocrine Bios-0.2-0.179.8310.6710.659.7410.72-0.19%▲-7.70%-7.87%1.24M
2013-07-25AMCNeurocrine Bios-0.2-0.1813.911414.0913.914.640.64%-1.28%-0.64%531.90K
2013-05-02AMC-0.1811.2510.910.9810.9211.460.73%2.46%3.21%1.25M
2013-02-08BMO-0.0810.8410.2310.6110.4210.993.71%2.17%5.96%813.41K
2012-10-31AMC-0.057.437.337.357.37.730.27%▲1.09%1.36%406.58K
2012-07-31AMCNeurocrine Bios-0.02-0.0177.67.716.997.751.45%-9.21%-7.89%723.60K
2012-05-02AMCNeurocrine Bios-0.016.997.377.386.987.40.14%-5.28%-5.16%894.60K
2012-02-08AMCNeurocrine Bios0.010.028.559.378.58.059.12-9.28%0.59%-8.75%1.92M
2011-10-31AMCNeurocrine Bios0.090.567.286.266.746.427.297.67%▲8.01%16.29%983.00K
2011-07-28AMCNeurocrine Bios0.060.047.737.987.817.678.04-2.13%-1.02%-3.13%352.60K
2011-05-03AMCNeurocrine Bios0.057.187.677.697.177.870.26%-6.63%-6.39%425.70K
2011-02-10AMCNeurocrine Bios0.047.847.348.397.88.414.31%-6.56%6.81%1.52M
2010-10-28AMCNeurocrine Bios0.058.148.228.218.128.5-0.12%▲-0.85%-0.97%486.90K
2010-07-28AMCNeurocrine Bios-0.175.425.465.55.375.650.73%-1.45%-0.73%281.60K
2010-04-28AMCNeurocrine Bios-0.243.223.263.253.163.35-0.31%-0.92%-1.23%272.40K
2010-02-03AMCNeurocrine Bios-0.282.172.342.342.152.42-7.26%-7.26%180.60K
2009-10-28AMCNeurocrine Bios-0.352.322.282.32.282.420.88%▲0.87%1.75%148.00K
2009-07-29AMCNeurocrine Bios-0.413.333.393.433.33.531.18%-2.92%-1.77%181.90K
2009-05-05AMCNeurocrine Bios-0.383.213.313.143.143.35-5.14%2.23%-3.02%154.20K

Login | Register
Saturday Oct 21, 2017   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.111.320.52%89,082,601

Upgrades/Downgrades